Kris Bieker-Brady will be moderating the panel covering biologics and biosimilars at the Life Sciences Patent Network “Protecting Innovation in a Changing Landscape.” She will be discussing the differences between biosimilars and generics matter, and if biologics necessitate date exclusivity protection.